You are using an outdated browser. Please upgrade your browser to improve your experience.

insulin glulisine

Ligand Summary
Description
Insulin glulisine [rDNA origin] is a rapid-acting human insulin analog used to lower blood glucose. Insulin glulisine is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12). Insulin glulisine differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid.
Synonyms & Links
DrugCentral: 5057
LyCHI:  insulin glulisine


loading...
Target Activities